INDSWFTLAB.NS
IND Swift Laboratories Ltd
Price:  
92.67 
INR
Volume:  
538,949.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INDSWFTLAB.NS WACC - Weighted Average Cost of Capital

The WACC of IND Swift Laboratories Ltd (INDSWFTLAB.NS) is 18.2%.

The Cost of Equity of IND Swift Laboratories Ltd (INDSWFTLAB.NS) is 18.40%.
The Cost of Debt of IND Swift Laboratories Ltd (INDSWFTLAB.NS) is 13.55%.

Range Selected
Cost of equity 16.50% - 20.30% 18.40%
Tax rate 30.00% - 30.00% 30.00%
Cost of debt 11.70% - 15.40% 13.55%
WACC 16.3% - 20.1% 18.2%
WACC

INDSWFTLAB.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 1.16 1.34
Additional risk adjustments 0.0% 0.5%
Cost of equity 16.50% 20.30%
Tax rate 30.00% 30.00%
Debt/Equity ratio 0.03 0.03
Cost of debt 11.70% 15.40%
After-tax WACC 16.3% 20.1%
Selected WACC 18.2%

INDSWFTLAB.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for INDSWFTLAB.NS:

cost_of_equity (18.40%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (1.16) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.